Mountain Sickness
📧 Sign up to get email alerts when something new happens for Mountain Sickness.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude [EARLY_Phase 1]
An early-stage clinical trial is evaluating whether acetazolamide can reduce inflammation and innate immune activation at high altitude. The…
-
FDA approval · 2026-04-02FDA Approved: ACETAZOLAMIDE — Supplemental Application (Lifestar Pharma LLC)
FDA approved a supplemental application for acetazolamide filed by Lifestar Pharma LLC under the ANDA program. The document does not specify…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Erythrocytapheresis for Chronic Mountain Sickness [NA]
This clinical trial update indicates that a study evaluating erythrocytapheresis for Chronic Mountain Sickness is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: The Psychophysiological Effect of Simulated and Terrestrial Altitude [NA]
The trial evaluated the psychophysiological effects of simulated and terrestrial altitude exposure; it is completed and results have been po…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Pharmacologic Induction of Tolerance for Hypoxia & Hypothermia
A University of Maryland–sponsored clinical trial is evaluating a pharmacologic approach to induce tolerance to hypoxia and hypothermia; the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: HighCycle Study: Effect of Acetazolamide on Acute Mountain Sickness in Women Compared to Men [Phase 4]
Phase 4 study assessing whether acetazolamide differently affects acute mountain sickness in women compared with men. The trial status is co…
-
FDA approval · 2026-01-12FDA Approved: ACETAZOLAMIDE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for acetazolamide. This action approves changes to the product associated wit…
-
FDA approval · 2026-01-08FDA Approved: ACETAZOLAMIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for acetazolamide from Strides Pharma Science Limited. The document indicates approval of a suppleme…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Efficacy of Positive Expiratory Pressure on Acute Mountain Sickness [NA]
This clinical trial update notes a study evaluating positive expiratory pressure as an intervention for Acute Mountain Sickness, with recrui…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: Voluntary Isocapnic Hyperpnea in Hypoxia to Mitigate Acute Mountain Sickness [NA]
ClinicalTrials.gov entry describing a study on using voluntary isocapnic hyperpnea in hypoxia to prevent acute mountain sickness. The trial …
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: HighCycle Study: Acetazolamide, High Altitude and Plasma Volume [Phase 4]
Phase 4 trial evaluating acetazolamide for high-altitude effects and plasma volume, with recruitment ongoing.
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Treatment of Chronic Mountain Sickness [NA]
A completed clinical trial update from Centre d'Expertise sur l'Altitude EXALT regarding treatment for chronic mountain sickness.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: The Effects of Artificial Air Negative Ions on High-Altitude Acclimatization, Serum HIF1, and PWC170 Index [NA]
A completed clinical trial evaluated whether artificial air negative ions affect high-altitude acclimatization, serum HIF-1 levels, and phys…
-
FDA approval · 2025-06-17FDA Approved: ACETAZOLAMIDE — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' Original Application for Acetazolamide, including Acetazolamide and Acetazolamide Sodium formulations.
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: HighCycle Study: Effect of High Altitude on Acute Mountain Sickness in Women Related to Their Menstrual Cycle Phase
A University of Zurich study examines whether high altitude exposure influences acute mountain sickness in women and whether the menstrual c…
-
FDA approval · 2025-05-30FDA Approved: ACETAZOLAMIDE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's original application for a generic acetazolamide product.
-
FDA approval · 2025-03-13FDA Approved: ACETAZOLAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for acetazolamide from ANI Pharmaceuticals, Inc., under ANDA 210588, indicating approval of a change…
-
FDA approval · 2025-03-12FDA Approved: ACETAZOLAMIDE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for acetazolamide submitted by Ajanta Pharma USA Inc.
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The Effect of Chronic Nitrate Supplementation on Acute Mountain Sickness and Exercise Performance in Hypoxia [NA]
This clinical trial update reports results from a completed study evaluating whether chronic nitrate supplementation affects acute mountain …
-
FDA approval · 2025-01-27FDA Approved: ACETAZOLAMIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Acetazolamide from Accord Healthcare Inc. under an Abbreviated New Drug Application.
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: CO2 Supplement for Treatment of Acute Mountain Sickness [NA]
A completed clinical trial evaluated inhaled carbon dioxide as a treatment for Acute Mountain Sickness.
-
FDA approval · 2024-12-12FDA Approved: ACETAZOLAMIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Acetazolamide from Alembic Pharmaceuticals Inc., indicating a supplemental approval for this gen…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness [Phase 2]
A Phase 2 randomized trial evaluates prochlorperazine maleate versus placebo for the prophylaxis of Acute Mountain Sickness; the study has c…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) [Phase 3]
Phase 3 clinical trial assessing the safety and efficacy of T89 for prevention and treatment of Acute Mountain Sickness in adults; study com…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill [Phase 2, Phase 3]
A randomized trial program (Phase 2/3) is evaluating the prevention of Acute Mountain Sickness with Suxiao Jiuxin Pill. The study status is …